Generics US-FDA
FDA Announces Improved Policies Regarding Transparency, Public Disclosure for Advisory Committees
The improvements include stricter limits on financial conflicts of interest for committee members, ...
Date:
08/05/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01871.html
FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs
...to require manufacturers of "conventional" antipsychotic drugs to make safety-related changes to prescribing information, or labeling, to warn about an increased risk of death...
Date:
06/16/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01851.html
Mom sues over infant's cold med death
Woman targets two drugmakers for not warning consumers of dangers
Date:
11/14/2007
, Publication:
MSNBC
, Author:
MICHAEL TARM Associated Press
http://www.msnbc.msn.com/id/21796308/
FDA to accelerate approval of generic drugs
Agency aims to increase number, availability of affordable meds
Date:
10/04/2007
, Publication:
MSNBC
, Author:
Associated Press
http://www.msnbc.msn.com/id/21137275/
FDA May Allow Pharmacists to Give Drugs without Prescriptions
The government is mulling more "behind-the-counter" sales, to let patients buy certain medicines directly from pharmacists without a doctor's prescription.
Date:
10/04/2007
, Publication:
Fox News
, Author:
Associated Press
http://www.foxnews.com/story/0,2933,299162,00.html
FDA Announces Initiative to Bolster Generic Drug Program
Effort will streamline generic drug approval process; provide more options for consumers, health professionals
Date:
10/04/2007
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01719.html
Tomorrow's Drugs
Seven top therapies and technologies vying to deliver the next decade's breakthroughs and blockbusters. They want to become...
Date:
07/30/2007
, Publication:
Pharmaceutical Executive
, Author:
The Staff of Pharmaceutical Executive
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=446938
Culture Shock- The withdrawal of Vioxx signaled a sea change. Welcome to the Culture of Drug SafetyDate:
07/03/2007
, Publication:
Pharmaceutical Executive
, Author:
Louis A. Morris
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=442280
From the Editor: Post-regulatory
The Acomplia story isn't ending. It's just beginning.
Date:
07/03/2007
, Publication:
Pharmaceutical Executive
, Author:
Patrick Clinton
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=442273
VIDEO Exclusive Video Interview with CDER Director, Steven Galson, MD VIDEO
Exclusive Video Interview with CDER Director, Steven Galson, MD on Drug Risks, Regulation and Research
Date:
06/24/2007
, Publication:
Pharmaceutical Executive
, Author:
Jill Wechsler
http://www.advanstar.com/test/pharmascience/pha-sci_supp-promos/phasci_reg_guid
Previous
Page 1 of 18
Next >
Search returned 177 items.
|
Sponsored Links
Reach these Drug Developers
Via Email or Mail List Rentals
www.biotechmedia.com
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
Smart strategic thinking and
innovative creative execution
www.adwise.com
|